Lilly settles Zyprexa marketing suit for $1.4 billion
Indianapolis-based Lilly pleaded guilty to one violation of the Food, Drug and Cosmetic Act on Thursday and agreed to pay $1.42 billion to settle both that criminal charge as well as civil lawsuits in...
View ArticleHealth care marketers taking the pulse of consumers' online habits
Health care marketers can adapt to, and even use to their advantage, the online search habits of consumers. Understanding when and why people search for specific health-related terms is vital to...
View ArticleLilly shares get boost from OK of rival's drug
Shares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators' clearance of a similar drug.
View ArticleLilly grows Alimta's sales by shrinking market
In 2008, Eli Lilly and Co. asked drug regulators to change the label on Alimta so Lilly could no longer promote it as a treatment for all patients suffering from non-small-cell lung cancer, but for...
View ArticleIndiana to get share of Botox settlement
Botox maker Allergan Inc. said it would pay $600 million to settle a years-long federal investigation into its marketing of the drug. Indiana will get $636,000 of that money.
View ArticleLilly discovers social media
Eli Lilly and Co. launched its own blog this month, dubbed LillyPad, to try to start discussions about public policy and corporate social responsibility. The Indianapolis-based drugmaker also launched...
View ArticleHospital systems adopt Starbucks-style service
Indiana University Health is the latest system to drill employees ranging from clerks to physicians in how to treat patients.
View ArticleStartup aims to mend doctors' social media woes
RepuChek software tracks, analyzes what's being said about doctors on the Internet.
View ArticleDecatur Vein Clinic branches out
In little more than a decade, former Conseco director Dr. David Decatur has turned his single-office family practice into a multistate chain of vein clinics. A 14th location is planned.
View ArticleNew drugmaker code deprives docs of football, lunch for 2
Doctors can still get free samples of medicines, but not football tickets or lunch for their spouses, under a revised code of conduct drafted by a global drug industry trade group that counts Eli Lilly...
View ArticlePatient referrals can be lucrative for hospitals
Physician liaisons are becoming key in recruiting efforts.
View ArticleSymbios collapse snares local investors
Symbios Medical Products LLC filed for Chapter 7 bankruptcy liquidation, costing numerous Indianapolis-area angel investors large sums.
View ArticleFirm aims to nationally distribute brain care innovation
Preferred Population Health Management is trying to get hospital systems, health insurers and area agencies on aging to use a set of tools and techniques to help dementia patients and their...
View ArticleEli Lilly chasing psoriasis jackpot with Taltz
Taltz, which hit the market last year, is taking on an armful of older treatments, including creams, lotions, pills and injectables, such as Amgen’s Enbrel and AbbVie’s Humira.
View ArticleLilly to disclose more information about drug pricing
Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will begin promoting a website where...
View Article
